Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

GLP-1s May Be Taking Our Eyes Off the Real Obesity Problem

(MedPage Today) -- GLP-1 receptor agonists may be powerful tools for treating obesity and cardiometabolic disease, but relying on medications alone risks overlooking the forces helping drive the obesity epidemic, according to Laura Schmidt, PhD...

GLP-1s May Be Taking Our Eyes Off the Real Obesity Problem

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 4 September →